RE: Chances of RNS next week?18 May 2020 08:54
Diluting the company by say 25% and starting clinical trials with 2m in your back pocket is just laughable...sure if they pick up 4m from srra, a couple of million from aurora and could dilute at 5-10% then it might be worth it but i would still have big reservations....sar dont have the capacity to go it alone like that and would have to hire a lot of 3rd party help which would cost serious money....it would be crazy to start a p1 without the funds to finish it and could put us in a very perilous state.
Anyway, with the sri work behind us and the testing done with the us army and china, i would be very concerned if we cannot get a deal at the end of pre-clin given that its a hot space....sar do preserve money quite well but placings have diluted the company 5 fivefold since i invested.
Its high time they move the company forward with deals and not dilution.